Company summary & AIM Rule 26 information
Main Page Content
| Primary Country Listing | UK |
|---|---|
| Status | AIM |
| Index | FTSE AIM All Share |
| Sector | Chemicals |
| Activities | Graphene NanoChem PLC designs, formulates and produces performance chemicals from renewable sources. It is also the mass-producer of graphene nanomaterials. |
| EPIC | GRPH |
| Overview from Annual Report | 31/12/2011 | 31/12/2010 |
|---|---|---|
| Ave. No. Employees (Excl. Directors) | 19 | 6 |
| Total Employee Cost | £0.155m | £0.181m |
| Gearing | 6.56% | -3.55% |
| ROCE | -7.33% | -5.94% |
| Latest Results - Interim | 30/06/2012 |
|---|---|
| Turnover (£m) | 0.3 |
| Pre-tax profit (£m) | -0.84 |
| EPS (undiluted and pre-exceptionals p) | -0.5 |
| Dividend (p) | 0 |
| Closing Share Price (p) | 120 | |
|---|---|---|
| Number of Shares in Issue (m) | 116.54 | |
| Market Capitalisation(£m) | 139.84 | |
The information below is being disclosed for the purposes of AIM Rule 26 and was last updated on 08 March 2013.
- Description of our business
- Directors
- Responsibilities of the members of the board of directors and details of committees
- Country of incorporation and main country of operation
- Biofutures International plc has not applied or agreed to have any of its securities (including its AIM securities) admitted or traded any other exchanges or trading platforms
- The number of AIM securities in issue is 166,445,000 and the percentage of AIM securities not in public hands is 22.40%. No shares are held in Treasury. The identity and percentage holdings of its significant shareholders are included in section Major shareholders.
- Our most recent admission document together with any circulars or similar publications sent to shareholders within the past 12 months:
Circular to shareholders
- Our current constitutional documents:
Memorandum of Association
Biofutures Articles of Association (August 2008, 260 kB pdf) - There are no restrictions on the transfer of Biofutures International plc's AIM securities
- Notifications made in past 12 months
- Our most recent admission document:
-
Biofutures Admission Document (March 2013, 5.57 MB pdf) -
Form of Proxy (March 2013, 48 kB pdf)
-
- Details of our nominated adviser and other key advisers
Access to this section of the website may be restricted under securities laws in certain countries. The following form requires you to enter your country of residence before you may obtain access to the information on this website.
Please confirm your country of residence:
Please confirm the country you are currently located in:
Disclaimer
ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY GRAPHENE NANOCHEM PLC IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY.
THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS IN THE UNITED STATES OR PERSONS RESIDENT OR LOCATED IN AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION ("EXCLUDED TERRITORIES").
The materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada, Japan, the Republic of South Africa or in any jurisdiction in which such offers or sales are unlawful. Any securities issued in connection with an offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or under any applicable securities laws of any state, province, territory, county or jurisdiction of the United States, Australia, Canada, Japan, or South Africa. Accordingly, unless an exemption under relevant securities laws is applicable, any such securities may not be offered, sold, resold, taken up, exercised, renounced, transferred, delivered or distributed, directly or indirectly, in or into the United States, Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration of such securities in, the relevant jurisdiction. There will be no public offer of securities in the United States.
The materials are only addressed to and directed at persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC) ("Qualified Investors"). In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, Qualified Investors who are persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or who are high net worth entities falling within Article 49 of the Order, and other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this document relates is available only to relevant persons in the United Kingdom and Qualified Investors in any member state of the European Economic Area other than the United Kingdom, and will only be engaged with such persons.
If you are located or resident in any Excluded Territory or you are in any doubt as to whether local law permits the distribution of these materials to you, please exit this webpage. These materials must not be released or otherwise forwarded, distributed or sent in or into the United States, Australia, Canada, Japan, the Republic of South Africa or any jurisdiction in which such offers or sales are unlawful. Persons receiving such documents (including custodians, nominees and trustees) must not distribute or send them in, into or from the United States, Australia, Canada, Japan, or the Republic of South Africa.
Confirmation of understanding and acceptance of disclaimer
I warrant that I am not a "U.S. person" as defined in U.S. Securities Act of 1933, as amended, I am not located in the United States and I am not resident or located in Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction where distribution of these materials is unlawful, and I agree that I will not transmit or otherwise send any materials contained in this website to any "U.S. person" or persons in the United States, Australia, Canada, Japan, the Republic of South Africa or any other territory where to do so would breach applicable local law or regulation.
I have read and understood the disclaimer set out above. I understand that it may affect my rights and I agree to be bound by its terms. I confirm that I am permitted to proceed to electronic versions of the materials.
Due to legal restrictions in your country of residence, you are not permitted access to these documents.
Go back to the page

